Improved Treatment Compliance With Medical Home Concept Will Benefit Pharmaceutical Industry

NASHVILLE, Tenn., Feb. 17 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the pharmaceutical industry stands to gain from the patient-centered medical home concept that continues to gain traction across the country. According to the recent New England Health Plan Analysis, medical home projects seek to maintain costs and improve health through better treatment compliance, including prescription drug regimens.

The medical home concept relies on a team-based approach where a primary-care physician provides coordinated care throughout a patient's lifetime, ultimately reducing hospitalizations and minimizing costs in the long run. Like pay-for-performance initiatives, the medical home payment model focuses more on outcomes than volume. On the provider side, physicians gain better monitoring tools, there is an increased focus on efficiency with physicians prescribing the most effective medications at the lowest cost, and care managers flagging duplicative tests and services. On the patient side, there are more discussions between the individual and the physician about his or her condition and treatment, with the expectation that a more informed, educated patient will be more compliant with treatment, including filling prescriptions and taking medications as prescribed.

"Pharmaceutical companies may stand to gain from the medical home movement, as patients become more educated and better monitored, and drug utilization and compliance increases," said Ric Gross, analyst with HealthLeaders-InterStudy. "However, the concept may prove to be a zero-sum game for pharma, where the most effective and least costly drugs gain share from those that are comparatively less effective or more costly."

Medical home projects highlighted in recent Health Plan Analysis reports include:

• Blue Cross & Blue Shield of Rhode Island has launched a medical home project and expects to have more than 100 primary-care physicians participating by the end of the year. The insurer also is part of a statewide, multi-payer chronic care medical home initiative.
• Blue Cross Blue Shield of Illinois has rolled out a patient-centered medical home pilot in the Chicago market that involves three large multi-specialty provider groups and 60,000 plan members, with a goal of at least doubling involvement in coming years.
• In Alabama, Blue Cross Blue Shield began a medical home pilot, the Alabama Health Improvement Initiative Medical Home Pilot, with about 70 physicians in family and internal medicine and pediatrics involved.

Why Pharmaceutical Companies Need Health Plan Analysis

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE HealthLeaders-InterStudy

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED